Trial Profile
A phase IIa trial of MP-101 for treatment of Alzheimer's disease psychosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs MP 101 Mediti Pharma (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 08 Jul 2016 New trial record